CS logo
small CS logo
Kitakyushu Municipal Medical Center

Kitakyusyu Shi, Fukoka, Japan
Medical center in Kitakyushu
2 Chome-1-番1号 Bashaku, Kokurakita Ward, Kitakyushu, Fukuoka 802-0077

About Kitakyushu Municipal Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
5
Janssen Research & Development, LLC
2
Amgen
1
Janssen-Cilag Ltd.
1
Pfizer
1
Total Rows: 5

Clinical Trials at Kitakyushu Municipal Medical Center


During the past decade, Kitakyushu Municipal Medical Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease
2016-12-14
2021-02-05
Completed
191
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
2018-06-18
2024-03-19
Recruiting
1,281
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
2018-07-18
2029-04-25
Recruiting
960
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
2018-10-19
2025-03-18
Active, not recruiting
1,177
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
2019-09-26
2029-09-29
Active, not recruiting
1,064
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
2020-06-22
2027-04-22
Recruiting
778
Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis
2022-01-31
2025-04-25
Recruiting
320
Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
2021-09-10
2023-12-01
Recruiting
96

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kitakyushu Municipal Medical Center" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Janssen-Cilag Ltd." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kitakyushu Municipal Medical Center" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Kitakyushu Municipal Medical Center


According to Clinical.Site data, the most researched conditions in "Kitakyushu Municipal Medical Center" are "Ulcerative Colitis" (6 trials), "Crohn's Disease" (2 trials), "Colitis, Ulcerative" (1 trials), "Fistulizing Crohns Disease" (1 trials) and "Perianal Crohns Disease" (1 trials). Many other conditions were trialed in "Kitakyushu Municipal Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Kitakyushu Municipal Medical Center


Most popular intervention types in "Kitakyushu Municipal Medical Center" are "Drug" (10 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Mirikizumab" (4 trials), "Guselkumab" (3 trials), "Efavaleukin alfa" (1 trials) and "Etrasimod" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kitakyushu Municipal Medical Center


The vast majority of trials in "Kitakyushu Municipal Medical Center" are 10 trials for "All" genders.

Clinical Trials Status at Kitakyushu Municipal Medical Center


Currently, there are NaN active trials in "Kitakyushu Municipal Medical Center". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kitakyushu Municipal Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kitakyushu Municipal Medical Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status